Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma

NEXT STORY
Herborium® Announces 4th Quarter Update Record Black Friday and Cyber Monday Sales Bring 15% Revenue Growth in 4th Quarter and Expected Highest Yearly Revenues On Record.
PREV STORY
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Forty Seven Inc. to Host Key Opinion Leader Breakfast Symposium on FSI-174, anti-cKIT Antibody, on January 22, 2019

MENLO PARK, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a ...

author_avatar
NASDAQ Market News

Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

author_avatar
NASDAQ Market News

Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update

author_avatar
NASDAQ Market News